In vivo metabolism and disposition of the nephrotoxicant N-(3, 5-dichlorophenyl)succinimide in Fischer 344 rats. 1998

R J Griffin, and P J Harvison
Department of Pharmaceutical Sciences, Philadelphia College of Pharmacy and Science, PA 19104-4495, USA

N-(3,5-Dichlorophenyl)succinimide (NDPS) was originally developed as an agricultural fungicide. Previous work indicated that NDPS-induced renal damage in rats is metabolism-dependent and that hydroxylated metabolites might be involved in the nephrotoxic response. In this study, the disposition and nephrotoxicity of [14C]NDPS at two time points (3 and 24 hr) and three doses (0.2, 0.4, and 0.6 mmol/kg) were examined in male Fischer 344 rats. At 3 hr, only approximately 6.0% of the administered dose (0.6 mmol/kg) had been excreted. Elimination was nearly complete by 24 hr, except at the highest dose. Urinary elimination far exceeded fecal elimination at all doses. The urinary metabolites were identified as N-(3, 5-dichlorophenyl)succinamic acid, N-(3, 5-dichlorophenyl)-2-hydroxysuccinamic acid, N-(3, 5-dichlorophenyl)-3-hydroxysuccinamic acid, and N-(3, 5-dichlorophenyl)malonamic acid. N-(3, 5Dichlorophenyl)-3-hydroxysuccinamic acid had not been previously detected in vivo. The same metabolites were also detected in the feces, blood, liver, and kidneys of rats. In addition, two novel in vivo NDPS metabolites were detected in liver and kidney homogenates. These metabolites were tentatively identified as N-(3, 5-dichlorophenyl)-2-hydroxysuccinimide and N-(3, 5-dichloro-4-hydroxyphenyl)succinamic acid. Dose-dependent increases in blood urea nitrogen levels, diuresis, proteinuria, glucosuria, and covalent protein adducts correlated with increases in oxidative metabolism. Rapid NDPS metabolism could help explain the early onset of nephrotoxicity. These studies provide additional evidence for the importance of oxidative metabolism in NDPS-induced kidney damage.

UI MeSH Term Description Entries
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D008297 Male Males
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011916 Rats, Inbred F344 An inbred strain of rat that is used for general BIOMEDICAL RESEARCH purposes. Fischer Rats,Rats, Inbred CDF,Rats, Inbred Fischer 344,Rats, F344,Rats, Inbred Fisher 344,CDF Rat, Inbred,CDF Rats, Inbred,F344 Rat,F344 Rat, Inbred,F344 Rats,F344 Rats, Inbred,Inbred CDF Rat,Inbred CDF Rats,Inbred F344 Rat,Inbred F344 Rats,Rat, F344,Rat, Inbred CDF,Rat, Inbred F344,Rats, Fischer
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D005659 Fungicides, Industrial Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. Industrial Fungicides
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.
D013388 Succinimides A subclass of IMIDES with the general structure of pyrrolidinedione. They are prepared by the distillation of ammonium succinate. They are sweet-tasting compounds that are used as chemical intermediates and plant growth stimulants. Butanimides,Pyrrolidinediones
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions

Related Publications

R J Griffin, and P J Harvison
June 1997, Fundamental and applied toxicology : official journal of the Society of Toxicology,
R J Griffin, and P J Harvison
December 2005, Drug metabolism and disposition: the biological fate of chemicals,
R J Griffin, and P J Harvison
January 1985, Toxicology letters,
R J Griffin, and P J Harvison
January 1995, Drug metabolism and disposition: the biological fate of chemicals,
R J Griffin, and P J Harvison
May 1999, Journal of toxicology and environmental health. Part A,
Copied contents to your clipboard!